ENA-001 for Post Operative Respiratory Depression (PORD)

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

March 15, 2026

Primary Completion Date

December 15, 2026

Study Completion Date

December 15, 2026

Conditions
Respiratory Depression
Interventions
DRUG

ENA-001

ENA-001 will be prepared in Ringer's lactate solution. A loading dose will be administered for 20 minutes followed by continuous infusion until the patient meets the criteria for PACU discharge (≥ 9 Aldrete score) or ABG reveals PaCO2 \< 30 mmHg with pH in the normal range. ENA-001 is for IV injection ready for use per subject by the investigational pharmacy, according to the randomization schedule.

Sponsors
All Listed Sponsors
lead

Enalare Therapeutics Inc.

INDUSTRY